Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127847881 | 12784788 | 1 | I | 2014 | 20160915 | 20160927 | 20160927 | EXP | FR-JNJFOC-20160924928 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160927 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127847881 | 12784788 | 1 | PS | IXPRIM | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Oral | U | U | 21123 | FILM COATED TABLET | ||||||||
| 127847881 | 12784788 | 2 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | N | 0 | 1 | G | UNSPECIFIED | BID | ||||||
| 127847881 | 12784788 | 3 | SS | THERALENE | TRIMEPRAZINE | 1 | Oral | U | 0 | 5 | MG | TABLET | BID | ||||||
| 127847881 | 12784788 | 4 | SS | TRIATEC | RAMIPRIL | 1 | Oral | U | 0 | 5 | MG | UNSPECIFIED | QD | ||||||
| 127847881 | 12784788 | 5 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | U | 0 | 20 | MG | UNSPECIFIED | QD | ||||||
| 127847881 | 12784788 | 6 | SS | STILNOX | ZOLPIDEM TARTRATE | 1 | Oral | U | 0 | 10 | MG | TABLET | QD | ||||||
| 127847881 | 12784788 | 7 | SS | SEROPLEX | ESCITALOPRAM OXALATE | 1 | Oral | U | 0 | 10 | MG | TABLET | BID | ||||||
| 127847881 | 12784788 | 8 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | U | 0 | 10 | MG | TABLET | QD | ||||||
| 127847881 | 12784788 | 9 | SS | CORTANCYL | PREDNISONE | 1 | Oral | U | 0 | 5 | MG | TABLET | BID | ||||||
| 127847881 | 12784788 | 10 | C | SERESTA | OXAZEPAM | 1 | Oral | D | 0 | 50 | MG | UNSPECIFIED | |||||||
| 127847881 | 12784788 | 11 | C | LASILIX | FUROSEMIDE | 1 | Oral | D | 0 | 40 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127847881 | 12784788 | 1 | Product used for unknown indication |
| 127847881 | 12784788 | 2 | Renal transplant |
| 127847881 | 12784788 | 3 | Thymus disorder |
| 127847881 | 12784788 | 4 | Hypertension |
| 127847881 | 12784788 | 5 | Prophylaxis against gastrointestinal ulcer |
| 127847881 | 12784788 | 6 | Insomnia |
| 127847881 | 12784788 | 7 | Thymus disorder |
| 127847881 | 12784788 | 8 | Hypercholesterolaemia |
| 127847881 | 12784788 | 9 | Renal transplant |
| 127847881 | 12784788 | 10 | Product used for unknown indication |
| 127847881 | 12784788 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127847881 | 12784788 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127847881 | 12784788 | Cough | |
| 127847881 | 12784788 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127847881 | 12784788 | 1 | 2014 | 0 | ||
| 127847881 | 12784788 | 2 | 2002 | 20160830 | 0 | |
| 127847881 | 12784788 | 3 | 2002 | 0 | ||
| 127847881 | 12784788 | 4 | 2002 | 0 | ||
| 127847881 | 12784788 | 5 | 2014 | 0 | ||
| 127847881 | 12784788 | 6 | 2009 | 0 | ||
| 127847881 | 12784788 | 7 | 2009 | 0 | ||
| 127847881 | 12784788 | 8 | 2002 | 0 | ||
| 127847881 | 12784788 | 9 | 2002 | 0 | ||
| 127847881 | 12784788 | 10 | 2015 | 0 | ||
| 127847881 | 12784788 | 11 | 2016 | 0 |